• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Five Major Areas of Advancement in Genomics/Genetics Expected for 2019 according to Wamberg Genomic Advisors

December 27, 2018 By admin Leave a Comment

For consumers, it will be the year we cross the chasm from recreational to clinical application of genetics testing

Wamberg Genomic Advisors (Wamberg), the first independent and trusted intermediary that objectively assesses genomic/genetic test labs and service providers, reports on expectations in genomics/genetics advances in 2019. Wamberg’s technical experts, led by Mark Winham, Chief Scientific and Operating Officer, constantly evaluate relevant scientific trends and genetic testing labs.

Regarding expectations in genomics/genetics for 2019, Winham said, “We expect that 2019 will be known as the year that the public discerns the difference between well-known genetic testing companies focused on genealogy, and those that deliver increasing clinical insights for disease risk and wellness management. For consumers, it will be the year we see the adoption of clinical genetic testing mirror the rise seen in recreational genetics. Notable changes will be an increase in the adoption of genetic risk testing of inherited disease such as cancer and heart disease. Even as we make these advances, we are still at the initial stages of genetic/genomic testing and its application in anticipating disease and determining preventive and care paths for patients.”

Winham noted five major areas of advancement in genetic/genomics in 2019 to include 1) accelerated adoption; 2) interpretation of genomic data; 3) RNA interpretation; 4) liquid biopsy; and 5) reproductive health.

Top-line insights on each of the five are below:

1. Accelerated adoption:

23andMe, Ancestry.com and MyHeritage have led the way from a consumer “recreational” perspective, getting people comfortable with genetics/genomics. Now, companies like Color Genomics, Inc., Invitae, Ambry Genetics, and Myriad Genetics are driving clinical adoption of genetic risk testing in cancer and heart conditions. According to Winham, these companies will help consumers understand that genetic risk testing has far reaching effects in understanding predisposition to disease and resulting approaches to wellness management and treatment. He expects that beyond heart disease and cancer, other chronic diseases of aging are likely to be adopted for genetic risk testing in the next year or two, for example: diabetes. On the other hand, he noted that the adoption of non-medically actionable conditions, including neurological conditions such as dementia, will remain in question by the medical community.
2. Interpretation of Genomic Data

Development and use of Polygenic Risk Scoring (a genome-wide score based on variation in multiple genetic factors for better prediction of genetic risk) will continue to rise. This will be enabled by a mix of machine learning, the generation and access to more genomic data, and access to quality phenotypic data. Polygenic Risk Scoring for heart disease, especially coronary artery disease is going through a step-change right now to identify people at risk. Also, more genomic data will be generated on diverse populations, expanding genomic data beyond that currently derived overwhelmingly from people of European descent.
3. RNA

RNA stands for ribonucleic acid. It is arguably more biologically relevant than DNA – a combined understanding in the variation and function of both DNA and RNA will be greater than the sum of the two parts. To date, testing and reporting of RNA modification and function has lagged DNA due to technical difficulties, but these are being overcome. Expect to see significant progress in the next one to two years.
4. Liquid Biopsy

Liquid biopsy is a term used for the capture and detection of DNA that has escaped from cells, or so-called cell-free DNA (cfDNA). Cell-free DNA was first used as a non-invasive pre-natal test to detect and analyze fetal DNA in blood instead of amniotic fluid. Liquid biopsy is now being extended as a less invasive means to capture and analyze the DNA that has escaped from a cancerous tumor, and has profound ramifications for the early detection of cancer, and as a “companion diagnostic” to gauge the effectiveness of cancer treatments. How to interpret the results of liquid biopsy in cancer has been a challenge, however large-scale clinical studies are now underway by companies such as Grail, and will improve utility over the next few years.
5. Reproductive Health

Carrier screening by prospective mothers and fathers is on the increase. Some individuals may undergo genetic testing to know their status, and only choose a genetically compatible partner to eliminate/reduce risk of hereditary disease. For IVF, we expect that embryos will be more routinely screened for inheritance of disease as part of selection for implantation. In addition, there may be increased “trio” testing (mother, father, child) to gain a better understanding of inheritance patterns and pre-disposition to disease in families.
About Mark Winham
Winham has 30+ years of industry experience, ranging from the clinical laboratory to medical device to life science operations. Previous companies include Sanofi, Johnson & Johnson, Advanced Medical Solutions, Applied Biosystems, Life Technologies, Millennium Health and Human Longevity. He has developed and applied many cellular and molecular biology techniques, and in recent years has worked extensively in the areas of DNA sequencing and genomics.

About Wamberg Genomic Advisors
Wamberg Genomic Advisors is the first company dedicated to making genomic-based programs and services, not typically covered by health insurance, available at prices everyone can afford. Advanced DNA testing can provide insights to individuals and health-care providers for better-informed decisions about overall health, patient-care paths, and the quality and longevity of life. Wamberg Genomic Advisors delivers genomic products and services to employers and their employees via their trusted benefit brokers, and to policyholders of life insurance companies through qualified agents. To discover more about Wamberg Genomic Advisors and the future of genomics, visit wamberggenomic.com and cancerguardian.com.

SOURCE Wamberg Genomic Advisors

Related Links

Programs and Services

Filed Under: PR

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

Open Source eCommerce as a Viable Alternative
The in-flight WiFi industry is expected to be worth $30 billion by 2035
AltCarne is the New Meat
$300bn of trapped value in people’s homes
When synthetic biology will disrupt an industry?
CryptoSupercycles.com: 2021, Year of Crypto
European Market for Veterinary Antibiotics

Market Research Media

MoscowRules.com (Moscow Rules): A Perfect Title for Publication Covering Russian Affairs
NFTmediamarketplace.com (NFT Media Marketplace): Who’s making the most money on the NFT boom?
QuasiQuantumCloud.com (Quasi Quantum Cloud): Accessibility to quantum simulation in the cloud is the game changer
The current market value for AR/VR/MR is around $30.7B, and the worldwide market may rise to $300B by 2024
Worldwide government IT spending is forecast to total $565.7 billion in 2022, an increase of 5% from 2021
Resilient Supplies: AI is the name of the game
SetupMarketplace.com: Setup Marketplace

Secondary Sidebar

Technologies

Blockchaining, AI and IoT are the three big technological developments that will change banking
SHORTAGES IN JOB-READY DIGITAL TALENT ARE STALLING ENTERPRISE INNOVATION
Portable Hydrogen Cartridge
EU moves to wean itself off Russian fossil fuels
New Greentech Start-Up, Refhuel, to Develop Reversible Fuel Cell Technology

Tech Events

Fira de Barcelona celebrates the extension of MWC Barcelona until 2030
COMPUTEX 2021 Virtual is now live through June 30
Bloomberg Technology Summit, June 8, 2022 San Francisco, CA & Virtual
RIT and SPIE Partner on 2021 Photonics for Quantum Event, 12-16 July, 2021
SPIE Photonics West Digital Forum Showcases Best of Optics, Photonics, Quantum, Biomedical Technologies in Applications and Research, 6-11 March, 2021

Footer

Recent Posts

  • Breakthrough VR Basketball App Gym Class Closes $8 Million in Seed Round Led by Andreessen Horowitz
  • Techstars and Audi Launch Pre-Accelerator Program to Promote Innovation in Mobility
  • Latchel Closes $16.7 Million to Enhance Resident Services and Maintenance Workflow
  • Seedtag raises over €250M from Advent International
  • Arable Raises $40 Million to Accelerate Sustainable Agriculture
  • European Quantum Computing Leader IQM Raises €128m Led by World Fund to Help Combat the Climate Crisis
  • Whatnot raises $260M Series D co-led by DST Global and CapitalG to expand its live, social commerce marketplace
  • ZeroAvia Secures Additional $30 Million in Funding from IAG, Barclays, NEOM & AENU
  • Medusa Raises $8m to Build the Leading E-Commerce Platform for Developers
  • Blue Ocean Barns Completes $20 Million Series A Financing, Accelerating Solution to Agricultural Methane Emissions

Dossier

Accenture to Acquire umlaut
Intel Makes Organizational Changes to Strengthen Execution, Innovation in Critical Business Areas
The US has enough people to close the labor gap
Microvast Joins Russell 3000® Index
euNetworks Acquires The Loop Manchester

Press Media Release

Jio Platforms Ltd and SES Announce Joint Venture to Deliver High-Performance Satellite-Based Broadband Services Across India
What happens to the Internet traffic in countries where many observe Ramadan?
American Legion hails start of Operation Allies Refuge, Calls for Evacuations to Pick Up Pace
Igniting Intelligence: Vayyar launches high-resolution mmWave tracker module
GlobalConnect keeps growing its customer base and accelerates sustainability efforts in Q2 2022

App Coding

Software can be classified into two categories
Ondat 2.8 Arrives in GA with Increased Support for Stateful Workloads in Kubernetes
Configit Introduces Breakthrough System-Level Configuration Solution
How to build a search engine
Machine learning algorithms cheat sheet

API Coding

RapidAPI opens European headquarters at the new location in Berlin
What is a REST API?
What is an API Gateway?
DarkOwl Announces Release of Ransomware API
DataGrail Launches API & Agent to Automate DSR Fulfillment Across All Internal Data Systems, Saving Companies Weeks of Engineering Time

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT